Cargando…

Impact of Regions with COVID-19 Cases on COVID-Zero Regions by Population Mobility — Worldwide, 2021

WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? Reducing population mobility and increasing the vaccination rate for severe acute respiratory syndrome coronavirus 2 can decrease the transmission of coronavirus disease 2019 (COVID-19). WHAT IS ADDED BY THIS REPORT? In order to reduce the incidence of COVID-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lianhao, Wang, Shiyi, Zhang, Xiangyu, Jia, Zhongwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837462/
https://www.ncbi.nlm.nih.gov/pubmed/35186374
http://dx.doi.org/10.46234/ccdcw2022.012
_version_ 1784649914244923392
author Wang, Lianhao
Wang, Shiyi
Zhang, Xiangyu
Jia, Zhongwei
author_facet Wang, Lianhao
Wang, Shiyi
Zhang, Xiangyu
Jia, Zhongwei
author_sort Wang, Lianhao
collection PubMed
description WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? Reducing population mobility and increasing the vaccination rate for severe acute respiratory syndrome coronavirus 2 can decrease the transmission of coronavirus disease 2019 (COVID-19). WHAT IS ADDED BY THIS REPORT? In order to reduce the incidence of COVID-19 to the levels of influenza after restoring normal mobility, the efficacy against infection needs to be increased to 40% and the efficacy against symptomatic disease needs to be increased to 90%. The efficacy against infection has a more important impact compared to efficacy against symptomatic disease or death on the transmission of COVID-19 at the population level. WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICE? The population should continue maintaining non-pharmaceutical interventions and minimize international movement to prevent transmission of COVID-19. Furthermore, developing new vaccines or promoting booster vaccinations should be considered to increase efficacy.
format Online
Article
Text
id pubmed-8837462
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-88374622022-02-18 Impact of Regions with COVID-19 Cases on COVID-Zero Regions by Population Mobility — Worldwide, 2021 Wang, Lianhao Wang, Shiyi Zhang, Xiangyu Jia, Zhongwei China CDC Wkly Preplanned Studies WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? Reducing population mobility and increasing the vaccination rate for severe acute respiratory syndrome coronavirus 2 can decrease the transmission of coronavirus disease 2019 (COVID-19). WHAT IS ADDED BY THIS REPORT? In order to reduce the incidence of COVID-19 to the levels of influenza after restoring normal mobility, the efficacy against infection needs to be increased to 40% and the efficacy against symptomatic disease needs to be increased to 90%. The efficacy against infection has a more important impact compared to efficacy against symptomatic disease or death on the transmission of COVID-19 at the population level. WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICE? The population should continue maintaining non-pharmaceutical interventions and minimize international movement to prevent transmission of COVID-19. Furthermore, developing new vaccines or promoting booster vaccinations should be considered to increase efficacy. Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2022-02-04 /pmc/articles/PMC8837462/ /pubmed/35186374 http://dx.doi.org/10.46234/ccdcw2022.012 Text en Copyright and License information: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2022 https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/)
spellingShingle Preplanned Studies
Wang, Lianhao
Wang, Shiyi
Zhang, Xiangyu
Jia, Zhongwei
Impact of Regions with COVID-19 Cases on COVID-Zero Regions by Population Mobility — Worldwide, 2021
title Impact of Regions with COVID-19 Cases on COVID-Zero Regions by Population Mobility — Worldwide, 2021
title_full Impact of Regions with COVID-19 Cases on COVID-Zero Regions by Population Mobility — Worldwide, 2021
title_fullStr Impact of Regions with COVID-19 Cases on COVID-Zero Regions by Population Mobility — Worldwide, 2021
title_full_unstemmed Impact of Regions with COVID-19 Cases on COVID-Zero Regions by Population Mobility — Worldwide, 2021
title_short Impact of Regions with COVID-19 Cases on COVID-Zero Regions by Population Mobility — Worldwide, 2021
title_sort impact of regions with covid-19 cases on covid-zero regions by population mobility — worldwide, 2021
topic Preplanned Studies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837462/
https://www.ncbi.nlm.nih.gov/pubmed/35186374
http://dx.doi.org/10.46234/ccdcw2022.012
work_keys_str_mv AT wanglianhao impactofregionswithcovid19casesoncovidzeroregionsbypopulationmobilityworldwide2021
AT wangshiyi impactofregionswithcovid19casesoncovidzeroregionsbypopulationmobilityworldwide2021
AT zhangxiangyu impactofregionswithcovid19casesoncovidzeroregionsbypopulationmobilityworldwide2021
AT jiazhongwei impactofregionswithcovid19casesoncovidzeroregionsbypopulationmobilityworldwide2021